Poxviral vectors for cancer immunother… [Expert Opin Biol Ther. 2012]
Via Scoop.it – Virology and Bioinformatics from Virology.ca
Poxviral vaccines have been given to over 1 billion people in the successful global eradication of smallpox. Recombinant poxviruses have been investigated extensively as a novel immunotherapy for cancer, undergoing several iterations to optimize their immunogenicity and efficacy.